Atlas Trials

Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19

Clinical trial NCT04889040 · TERMINATED

Trial details

NCT number
NCT04889040
Sponsor
Hoffmann-La Roche
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2021-04-28
Primary completion
2021-12-02
Enrollment
216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.